42 / 120
3/9/2017
2
SPSFAM
Cannabis Working Group Members
•
Susan Audino, Audino & Associates
•
Patricia Atkins, SPEX
•
Roger Brauinger, A2LA
•
Paula Brown, BCIT
•
Carolyn Burdette, NIST
•
Bob Clifford, Shimadzu
•
Jo Marie Cook, Florida Dept. of Ag
•
Jennifer Donelson, VUV
•
Kevin George, Eurofins
•
Peter Gibson, GW Pharmaceuticals
•
Thomas Hartlein, Teledyne Tekmar
•
Dorota Inerowicz, Indiana State Chemist
•
Holly Johnson, Alkemist
•
Erik Konings, Nestlé
•
Julie Kowalski, Phenomenex
•
Mary Kay Krogull, Eurofins
•
Julie Kowalski, Restek
•
Scott Kuzdal, Shimadzu
•
Robert Lockerman, CEM
•
Cynthia Ludwig, SAgE
•
Kate Mastovska, Covance
•
Elizabeth Mudge, BCIT
•
Gary Niehaus, Crystal Diagnostics
•
Masayuki Nishimuram Shimadzu
•
Melissa Phillips, NIST
•
Curtis Phinney, Consultant
•
Klaus Reif, PhytoLab GmbH
•
Mitzi Rettinger, Millipore Sigma
•
Kate Rimmer, NIST
•
Adam Ross, LGC Standards
•
Travis Ruthenburg, SC Labs
•
Alicia Stell, CEM
•
Alan Sutton, GW Pharma
•
Aniko Solyom, GAAS Analytical
•
Kathy Stenerson, MilliporeSigma
•
John Szpylka, Mérieux Nutrisciences
•
Jane Weitzel, Consultant
•
Seth Wong, TEQ Analytical
•
Josh Wurzer, SC Labs
•
Hong You, Eurofins
Background
Perspective:
Cannabis Industry Expected to be Worth $50
Billion by 2026 (Bloomberg Markets Report,
September 12, 2016)
Estimated size of the legal US industry (MMJ
and Recreational): $7.1 Billion in 2016,
increased more than 25% from 2015
89% of Americans support legalization of
medicinal use. Increased 15% since 2011.
56% Physicians support nationwide legalization
of medicinal cannabis.